SCHEMBL16539243

SCHEMBL16539243

COc1ccc(C(=O)/C=C/c2cc(-c3ccc4c(c3)OCO4)n[nH]2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.56
▸ POLB P06746 4/20 0.56
▸ ALDH1A1 P00352 3/20 0.56
▸ LMNA P02545 3/20 0.56
▸ THRB P10828 2/20 0.56
▸ HPGD P15428 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ TNFRSF1A P19438 3/20 0.54
▸ RAB9A P51151 4/20 0.53
▸ STAT1 P42224 1/20 0.53
▸ NPC1 O15118 3/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ GFER P55789 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ ABCG2 Q9UNQ0 3/20 0.47
▸ PTGS1 P23219 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16539248 1.00 MAPT (0.56) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16539259 0.96 TNFRSF1A (0.56) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16539252 0.96 TNFRSF1A (0.56) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL17930352 0.92 TNFRSF1A (0.54) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16539300 0.92 TNFRSF1A (0.52) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16539293 0.92 TNFRSF1A (0.52) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16538963 0.90 TNFRSF1A (0.55) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16538966 0.90 TNFRSF1A (0.55) MAPTPOLBALDH1A1LMNATHRB
SCHEMBL16539443 0.89 MAPT (0.55) MAPTPOLBALDH1A1LMNANPSR1
SCHEMBL16539440 0.89 MAPT (0.55) MAPTPOLBALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3039013-B1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL SCIENT IND RES (IN) 2018-09-12 — — EP disclosed
US-9604933-B2 Pyrazolochalcones as potential anticancer agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-03-28 — — US disclosed
US-9604933-B2 Pyrazolochalcones as potential anticancer agents COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-03-28 — — US disclosed
US-20160207888-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-21 — — US disclosed
US-20160207888-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-21 — — US disclosed
EP-3039013-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS Council of Scientific and Industrial Research (IN) 2016-07-06 — — EP disclosed
WO-2015029051-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-03-05 — — WO disclosed
WO-2015029051-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207888-A1 PYRAZOLOCHALCONES AS POTENTIAL ANTICANCER AGENTS HCCS, CCNE2, FOXO3 MAPT 4760/4885POLB 3217/4885ALDH1A1 2565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback